Regents of the University of California portfolio
Foundation or endowmentPortfolio as of Sep 30, 2026 (Q3 2026) · filed with the SEC on Oct 26, 2026 · data updated on Nov 5, 2026 · Q3 2026 13F (filing) ↗ · all its 13F filings ↗
A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.
Regents of the University of California reported a $6.6 bn portfolio of 11 positions to the SEC as of the end of Q3 2026. Its largest positions are State Street Spdr UC Investmen, STT, SPCX.
Sections with a free account
What changed this quarter
7 positions with a change (2 new, 1 added to, 1 trimmed, 3 sold); also, 1 entered through an IPO. 1 is listed here: those of 0.5 points of the portfolio or more (up to 12).
- Newly listedState Street Spdr UC Investmen37.6% of the portfolio
It started trading this quarter: it appears in a 13F for the first time. The filing does not say whether the manager already held it before the listing, so it is not counted as a purchase.
- Blue OWL Technology Finance−11%fewer sharesReduced10.3% → 5.7%
The figure on the right: for positions added to or trimmed, the change in the number of shares (%); for new and sold ones, the points of the portfolio moved (pp). Below, the portfolio weight before → after. Traded weight: what it bought or sold, excluding price effects.
Top holdings
- State Street Spdr UC Investmen37.6%
- State StreetSTT26.0%
- Space Exploration TechnologiesSPCX14.1%
- ASML HoldingASML9.6%
- Blue OWL Technology FinanceOTF5.7%
- BrookfieldBN4.9%
- SPDR Gold Minishares Trust ETFGLDM1.8%
- BridgeBio Oncology TherapeuticsBBOT0.2%
- Eikon TherapeuticsEIKN0.1%
- SurrozenSRZN0.1%
- Blue OWL CapitalOWLunder 0.1%
“Since”: first quarter of the current run, unbroken until today. In the details, prices are the quarter-end prices of the quarters in which it added shares, per the 13F. The manager may have bought at any price within each quarter; the SEC only publishes the value at quarter end.
Portfolio by sector
- ● No sector 45%
- ● Financials 31%
- ● Industrials 14%
- ● Information Technology 10%
How its portfolio changed (8 quarters)
Q3 2026: 11
Q3 2026: 100%
Q3 2026: 19.5%
Traded turnover: the weight it bought plus the weight it sold in the quarter, divided by two, excluding price moves. The plain “turnover” in the header does include that effect. With a free account: the full history and sectors over time.
13F filings with amendments or confidential positions
- 13F Q1 2026 ↗filed May 8, 2026Amendment of May 28, 2026 (replaces the original) ↗
- 13F Q4 2025 ↗filed Feb 11, 2026Amendment of May 28, 2026 (replaces the original) ↗
- 13F Q3 2025 ↗filed Nov 6, 2025Amendment of May 28, 2026 (replaces the original) ↗
- 13F Q2 2025 ↗filed Aug 12, 2025Amendment of May 28, 2026 (replaces the original) ↗
Stakes above 5% (13D/13G)
Companies where this filer reported holding 5% or more of the shares. It is the figure from its latest filing on each one; history since December 2024.
How we classify it
Not counted as a concentrated manager: more than 20% is ETFs; it is a foundation or endowment; what it reports is usually donated stock or the direct slice of a portfolio run by others. Its portfolio is shown all the same, but it is left out of manager counts, the consensus and the ranking. How this is decided
Managers of a similar size
A 13F portfolio value between a third and three times this one, whatever the type of filer. It is not a comparison of what they hold.
- Reaves W HInvestment firm · $6.6 bn
- Ruane, Cunniff & GoldfarbInvestment firm · $6.4 bn
- Alpha Wave GlobalInvestment firm · $6.2 bn
- Longview Partners (Guernsey)Investment firm · $6.2 bn
- Slate Path CapitalInvestment firm · $7.2 bn
- Soros Fund Management$6.1 bn